Literature DB >> 7554490

Crohn's disease is accompanied by changes in the CD4+, but not CD8+, T cell receptor BV repertoire of lamina propria lymphocytes.

B Gulwani-Akolkar1, P N Akolkar, M McKinley, S E Fisher, J Silver.   

Abstract

To identify disease-specific T cell changes that occur in Crohn's disease (CD), the T cell receptor (TCR) BV repertoires of lamina propria lymphocytes (LPL) isolated from the diseased colon of seven CD patients and eight controls were determined by semiquantitative polymerase chain reaction (qPCR). As an internal control for the effects of HLA and other genes on the TCR repertoire, the BV repertoires of peripheral blood lymphocytes (PBL) from the same individuals were similarly determined and used for comparison. It was observed that the BV repertoires of LPL and PBL within the same individual were very different in both the CD and control groups. However, the CD4+, but not CD8+, repertoires of LPL and PBL differed to a much greater extent in the CD group than in the control group. Furthermore, in each CD patient there was a unique pattern of BV segments which were increased in the CD4+ LPL repertoire relative to that in PBL. These observations suggest that the inflammatory process in CD involves responses by specific CD4+ T cells to specific antigens. The isolation of such inflammation-specific CD4+ T cells may make it possible to identify the antigens which are responsible for the inflammatory process in CD and provide a better understanding of its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554490     DOI: 10.1016/0090-1229(95)90142-6

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  9 in total

1.  Oligoclonal expansions of mucosal T cells in Crohn's disease predominate in NKG2D-expressing CD4 T cells.

Authors:  M Camus; S Esses; B Pariente; L Le Bourhis; C Douay; V Chardiny; I Mocan; K Benlagha; E Clave; A Toubert; L Mayer; M Allez
Journal:  Mucosal Immunol       Date:  2013-08-14       Impact factor: 7.313

2.  Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease.

Authors:  L Lih-Brody; S R Powell; K P Collier; G M Reddy; R Cerchia; E Kahn; G S Weissman; S Katz; R A Floyd; M J McKinley; S E Fisher; G E Mullin
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

3.  Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease.

Authors:  A Cariappa; B Sands; D Forcione; D Finkelstein; D K Podolsky; S Pillai
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

4.  Splenic T helper cell type 1 cytokine profile and extramedullary haematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD).

Authors:  S Bregenholt; M H Claesson
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

5.  Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease.

Authors:  B Gulwani-Akolkar; P N Akolkar; A Minassian; R Pergolizzi; M McKinley; G Mullin; S Fisher; J Silver
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

6.  Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue.

Authors:  Anna M Sherwood; Ryan O Emerson; Dominique Scherer; Nina Habermann; Katharina Buck; Jürgen Staffa; Cindy Desmarais; Niels Halama; Dirk Jaeger; Peter Schirmacher; Esther Herpel; Matthias Kloor; Alexis Ulrich; Martin Schneider; Cornelia M Ulrich; Harlan Robins
Journal:  Cancer Immunol Immunother       Date:  2013-06-16       Impact factor: 6.968

7.  Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease.

Authors:  Nobuhide Oshitani; Fumihiko Hato; Seiichi Kitagawa; Kenji Watanabe; Yasuhiro Fujiwara; Kazuhide Higuchi; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

8.  Heterogeneity of HPLC profiles of human class II MHC-bound peptides isolated from intestine with inflammatory bowel disease.

Authors:  Nobuhide Oshitani; Fumihiko Hato; Yoshio Jinno; Yoshinori Sawa; Junichi Hara; Shiro Nakamura; Takayuki Matsumoto; Tetsuo Arakawa; Atsuo Kitano; Seiichi Kitagawa; Tetsuo Kuroki
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

9.  Bacterial superantigens and T cell receptor beta-chain-bearing T cells in the immunopathogenesis of ulcerative colitis.

Authors:  N Shiobara; Y Suzuki; H Aoki; A Gotoh; Y Fujii; Y Hamada; S Suzuki; N Fukui; I Kurane; T Itoh; R Suzuki
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.